Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (Jan 2020)

Brain amyloid and the transition to dementia in Down syndrome

  • David B. Keator,
  • Eric Doran,
  • Lisa Taylor,
  • Michael J. Phelan,
  • Christy Hom,
  • Katherine Tseung,
  • Theo G. M. vanErp,
  • Steven G. Potkin,
  • Adam M. Brickman,
  • Diana H. Rosas,
  • Michael A. Yassa,
  • Wayne Silverman,
  • Ira T. Lott

DOI
https://doi.org/10.1002/dad2.12126
Journal volume & issue
Vol. 12, no. 1
pp. n/a – n/a

Abstract

Read online

Abstract Introduction Down syndrome (DS) is associated with elevated risk for Alzheimer's disease (AD) due to amyloid beta (Aβ) lifelong accumulation. We hypothesized that the spatial distribution of brain Aβ predicts future dementia conversion in individuals with DS. Methods We acquired 18F‐florbetapir positron emission tomography scans from 19 nondemented individuals with DS at baseline and monitored them for 4 years, with five individuals transitioning to dementia. Machine learning classification using an independent test set determined features on 18F‐florbetapir standardized uptake value ratio maps that predicted transition. Results In addition to “AD signature” regions including the inferior parietal cortex, temporal lobes, and the cingulum, we found that Aβ cortical binding in the prefrontal and superior frontal cortices distinguished subjects who transitioned to dementia. Classification did well in predicting transitioners. Discussion Our study suggests that specific regional profiles of brain amyloid in older adults with DS may predict cognitive decline and are informative in evaluating the risk for dementia.

Keywords